Table 3.
Within group and between group differences in the percentages of patients achieving their individual therapeutic targets
| Target | Group | M0 n/N (%) | M24 n/N (%) | OR (95% CI) within groups | P-value | OR (95% CI) between groups | P-value |
|---|---|---|---|---|---|---|---|
| Blood pressurea |
Intervention |
207/900 (23.0) |
303/823 (36.8) |
2.55 (1.96 to 3.30) |
< 0.001 |
2.03 (1.44 to 2.88) |
< 0.001 |
| Usual care |
392/923 (42.6) |
382/825 (46.3) |
1.25 (0.99 to 1.58) |
0.060 |
|||
| LDL cholesterolb |
Intervention |
370/884 (41.9) |
458/793 (57.8) |
2.65 (2.05 to 3.41) |
< 0.001 |
1.25 (0.88 to 1.78) |
0.205 |
| Usual care |
395/910 (43.4) |
435/778 (55.9) |
2.11 (1.65 to 2.71) |
< 0.001 |
|||
| No smoking |
Intervention |
712/905 (78.7) |
664/804 (82.6) |
3.75 (1.92 to 7.30) |
< 0.001 |
0.81 (0.41 to 1.60) |
0.550 |
| Usual care |
709/926 (76.6) |
659/808 (81.6) |
2.98 (1.81 to 4.93) |
< 0.001 |
|||
| HbA1cc |
Intervention |
312/519 (60.1) |
275/472 (58.3) |
0.81 (0.58 to 1.16) |
0.257 |
0.77 (0.47 to 1.27) |
0.310 |
| Usual care |
316/512 (61.7) |
279/452 (61.7) |
1.06 (0.74 to 1.53) |
0.747 |
|||
| Low-dose aspirin |
Intervention |
225/527 (42.7) |
318/527 (60.3) |
5.55 (3.61 to 8.54) |
< 0.001 |
2.28 (1.27 to -4.09) |
0.006 |
| Usual care | 140/521 (26.9) | 179/521 (34.4) | 2.43 (1.57 to 3.77) | < 0.001 |
CI, confidence interval; M0, month 0; M24, month 24; OR, odds-ratio.
a ≤ 140/90 mmHg or ≤ 130/80 mmHg for type-2 diabetic patients.
b ≤ 3.36 mmol/l or 2.59 mmol/l for type-2 diabetic patients.
c ≤ 7%.